Children’s Hospital at Montefiore Einstein

Children's Hospital at Montefiore Einstein (CHAM) is a cornerstone in pediatric healthcare, annually serving a diverse community of over 200,000 children and spearheading advancements in medical research and education. Since 2001, with $441 million in research funding, including more than $165 million from the National Institutes of Health (NIH), CHAM has maintained its position as a leader in pediatric research. As a premier academic institution, CHAM is committed to cultivating future pediatric leaders with a curriculum focused on quality improvement, ethics, health equity and social justice, ensuring the highest standard of care for all children.


2023 by the numbers


children in the community received care


pediatric emergency department visits


peer-reviewed papers published


secured in research funding, including more than $165M from NIH


Montefiore Einstein Continued as a Center of Excellence for Neurofibromatosis

Montefiore Einstein was approved by the Children’s Tumor Foundation (CTF) to continue under the CTF Neurofibromatosis Clinic Network Affiliate clinic status as a Center of Excellence for Neurofibromatosis. This status, valid through December 31, 2023, was achieved through the collaborative efforts of multiple subspecialties including Epilepsy, Neuro-Oncology, Neurosurgery, Ophthalmology, Dermatology, Genetics, Nephrology, Cardiology, Neuroradiology, Neuropsychology and Rehabilitation Medicine.

CHAM-CHL Welcomed 14 New Students

On January 5, 2023, CHAM Community Health Leaders (CHAM-CHL) began the year by welcoming 14 new students, increasing its cohort to 24 aspiring pre-health scholars. Since its launch in October 2021, CHAM-CHL has been dedicated to fostering future leaders in pediatric medicine and enhancing diversity in the field. The program proudly contributes to the development of a close-knit community of future healthcare professionals.

Dr. David Loeb Awarded Alex’s Lemonade Stand Foundation Innovation Grant

Dr. David Loeb was awarded a $250,000 Innovation Award grant by the Alex’s Lemonade Stand Foundation for his groundbreaking research on sarcoma. His study, titled "The Impact of the Intestinal Microbiome on Sarcoma Metastasis," aims to investigate how the gut microbiome influences the progression of Ewing Sarcoma and Osteosarcoma. This project marks the first-ever study to characterize the intestinal microbiome in children with solid tumors.

Dr. David Loeb Awarded Department of Defense Grant for Pioneering Ewing Sarcoma Research

David Loeb, MD, PhD, received a $400,000 Idea Award grant from the Department of Defense for his research on Ewing sarcoma. Running from September 2023 to August 2025, his study, "Treatment-Induced Metastasis in Ewing Sarcoma," aims to explore how neoadjuvant chemotherapy and radiation might inadvertently spread sarcoma cells from the primary tumor. The research will also examine the potential of therapies targeting tumor-associated macrophages or endothelial cells to counteract this effect.

Dr. Denis Traore Honored with Health Equity Advocate Award

Denis Traore, MD, was honored with the Health Equity Advocate Award by Reach Out and Read of Greater New York on April 17, 2023. This award recognizes medical professionals who have significantly contributed to the development and implementation of Social Determinants of Health (SDOH) screenings and their integration into clinical or hospital practices.

Dr. Elisa I. Muñiz Receives Major Grant for Developmental-Behavioral Pediatrics (DBP) Training

Elisa I. Muñiz, MD, was awarded the T77 DBP Training Program Award by the Health Resources and Services Administration’s Maternal and Child Health Bureau. The award, totaling $1,323,480 and spanning from July 2018 to June 2028, supports the Einstein/CHAM DBP Training Program. This program is one of only 13 in the nation dedicated to preparing the next generation of leaders in maternal and child health to address the needs of individuals with developmental disabilities and behavioral challenges.

Dr. Beatrice Goilav Appointed as Chair of the Graduate Medical Education Committee (GMEC)

Beatrice Goilav, MD was appointed as chair of the GMEC at Montefiore Einstein on November 1, 2022. In this role, she leads the committee, which includes over 100 program directors, associate program directors, peer-selected house staff, program coordinators and GME administrators. Dr. Goilav is responsible for ensuring compliance with ACGME rules and regulations and will use her extensive experience in medical education to provide leadership and mentorship within the GME Community.

Dr. Marina Reznik Awarded Grant for Innovative Asthma Research

Marina Reznik, MD, received a $250,000 grant from the Monaghan Medical Corporation for her research project titled “Electronic Monitoring of Spacer and Controller Inhaler Use in Children with Asthma.” The study aims to evaluate the effectiveness of electronic sensors in monitoring inhaler and spacer usage among children with asthma. This research will gather data on inhaler technique, asthma control and medication adherence, using advanced electronic tracking technology.

Dr. Solomon Moshé Honored with Lifetime Achievement Award

Solomon (Nico) Moshé, MD, was honored with the prestigious 2023 Lifetime Achievement Award by the International League Against Epilepsy (ILAE) and the International Bureau of Epilepsy (IBE) on September 2, 2023. This award, the highest honor bestowed by the ILAE/IBE, recognizes individuals who have dedicated their careers to enhancing the lives of people with epilepsy. Dr. Moshé's exceptional contributions to the field have significantly impacted epilepsy care and research.

Dr. Melissa Wasserstein Named Raizin Distinguished Faculty Scholar in Pediatrics

On September 18, 2023, Melissa Wasserstein, MD, was honored with the title of Raizin Distinguished Faculty Scholar in Pediatrics. This prestigious recognition highlights Dr. Wasserstein's outstanding contributions in research, leadership and mentorship within the field of pediatrics, underscoring her significant impact and dedication to advancing pediatric healthcare and education.

Dr. Michael D. Cabana Appointed Editor-in-Chief

In July 2023, Michael D. Cabana, MD, MPH, was appointed Editor-in-Chief of the open-access version of the Journal of Pediatrics, which will be named the Journal of Pediatrics: Clinical Practice.

Team News

Updates and additions to our world-renowned faculty

Kevin P. Fiori, MD, MPH, MSc, FAAP

Chief, Community and Population Health
Vice Chair for Community Health & Engagement
Associate Professor of Pediatrics
Associate Professor of Family and Social Medicine

Amanda C. North, MD

Chief, Pediatric Urology
Associate Professor, Pediatric Urology

Shantanu Rastogi, MD

Chief, Neonatology

Deepa Rastogi, MD

Chief, Pediatric Respiratory and Sleep Medicine

Ibrahim Abdullah, MD

Chief, Pediatric Cardiothoracic Surgery
ECMO, Heart Transplantation
Co-Director, Pediatric Heart Center

Kimberly J. Reidy, MD, FAAP

Chief, Pediatric Nephrology
Associate Professor of Pediatrics

Nicole J. Sutton, MD

Chief, Pediatric Cardiology
Director of Invasive Cardiology
Associate Professor of Pediatrics
Director, Pediatric Pulmonary Hypertension Program
Co-Director, Pediatric Heart Center

Laurie E. Cohen, MD

Chief, Pediatric Endocrinology and Diabetes

Ronald C. Samuels, MD

Associate Chief for Complex Care
Medical Director, LINCS Complex Care Program

Mandana Behbahani, MD

Co-Director, Surgical Neuro-Oncology
Assistant Professor, Pediatric Neurosurgery

Andrew J. Kobets, MD, MHS

Co-Director, Surgical Neuro-Oncology
Assistant Professor, Pediatric Neurosurgery

Advancing pediatric healthcare through research

Annually, CHAM provides care for over 8,000 hospitalized infants, children and adolescents with complex conditions, including 1,100 in its pediatric critical care unit and around 1,000 critically ill newborns in neonatal intensive care units. Additionally, nearly 200,000 children are treated through pediatric ambulatory care, and 44,000 receive care in school-based health programs.

CHAM is recognized for groundbreaking research leading to new therapies and better outcomes. In 2023, CHAM received over $50 million in grants and contracts, with $15 million from the NIH, ranking it among the top 35 institutions for pediatric disease funding nationally.


Improving care and outcomes through research

Over the course of the year, CHAM published over 300 peer-reviewed papers across a variety of topics.

Explore our latest


Clinical Trials

Advancing care through clinical trials

Children's Hospital at Montefiore Einstein participates in both national and clinical trials, a selection of which are highlighted below.

Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS)

Marina Reznik, MD, MS

Molecular Basis of Early Childhood Obesity Programming by Intrauterine Growth Restriction

Maureen J. Charron, PhD
Mamta Fuloria, MD

Promoting Asthma Guidelines and Management Through Technology-Based Intervention and Care Coordination (PRAGMATIC)

Marina Reznik, MD, MS

NY ScreenPlus: A Comprehensive, Flexible, Multi-Disorder Newborn Screening Program

Melissa P. Wasserstein, MD

Bone In CKD Alkali Response Pilot Trial (BICARb Pilot Trial)

Kimberly Reidy, MD

Engagement and Depression in Adolescents and Young Adults with Childhood-Onset Lupus

Tamar Rubinstein, MD, MS

Targeting DKK-1 To Prevent Osteosarcoma Metastasis

David Loeb, MD, PhD

B7-H3 in Medulloblastoma: Evaluating its Expression and Function to Harness New Therapeutic Targets

Allison Martin, MD

Patient referrals

At Children’s Hospital at Montefiore Einstein (CHAM), we know that providing patients with the best possible care includes teamwork and trust. We work closely with our valued referring physicians to ensure open communication and reliable expertise.


Visit us

Children’s Hospital at Montefiore Einstein  
3415 Bainbridge Ave
Bronx, NY 10467